Centrue Financial Corp. (CFCB) 0.4000 $CFCB Centrue

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Centrue Financial Corp. (CFCB) 0.4000 $CFCB

Centrue Financial Corporation Announces 2014 Results
Marketwired - Tue Feb 10, 5:00PM CST
Centrue Financial Corporation (OTCQB: CFCB) (OTC PINK: CFCB)

Nasdaq stocks posting largest percentage decreases
AP - Tue Dec 16, 12:20PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
LNCO: 9.81 (+0.52), ORMP: 3.93 (-0.05), INFI: 15.39 (-1.14), LINE: 11.24 (+0.08), ORPN: 6.30 (unch), JAXB: 48.12 (+37.52), CLMT: 25.75 (-0.53), OBAS: 6.40 (-0.05)

Centrue Financial Corporation Announces the Sale of Classified Loans and REO in Bulk Sale
Marketwired - Tue Dec 09, 6:00AM CST
Centrue Financial Corporation (the "Company" or "Centrue" (OTCQB: CFCB) (OTC PINK: CFCB), parent company of Centrue Bank (the "Bank", announced today that the Bank sold $35.2 million of classified loans and REO, at a discount of approximately 23% of their carrying value. This bulk sale resulted in a pre-tax charge to 2014 earnings of $4.5 million.

Centrue Financial Corporation Announces 2014 Third Quarter Results
Marketwired - Wed Nov 05, 3:16PM CST
Centrue Financial Corporation (OTCQB: CFCB) (PINKSHEETS: CFCB)

Centrue Financial Corporation Announces Agreement for Proposed $75.0 Million Equity Recapitalization; Special Stockholder Meeting Scheduled
Marketwire - Mon Aug 11, 11:00AM CDT
Centrue Financial Corporation (the "Company" or "Centrue" (OTCQB: CFCB) (PINKSHEETS: CFCB), parent company of Centrue Bank, announced today that it has entered into a stock purchase agreement with certain affiliates of Capital Z Partners III, L.P. ("Cap Z" as lead investor of a proposed capital raise of an aggregate $75 million, or 187,500,000 shares of common stock at a price of $0.40 per share. The agreement contemplates that Cap Z will own 24.0% of the Company's outstanding common stock after the transaction is complete. The securities issued in the recapitalization will not be registered under the Securities Act of 1933, as amended, or the securities laws of any state, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Centrue Financial Corporation Announces 2014 Second Quarter Results
Marketwire - Fri Aug 01, 6:00AM CDT
Centrue Financial Corporation (OTCQB: CFCB) (PINKSHEETS: CFCB)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 44

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 44

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 61

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 38

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 56

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 46

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 48

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Cemtrex's Stock Surge Sparks Interest in Leading Movers

Updated Category News Views 117

Cemtrex Experiences Notable Share Surge Shares of Cemtrex, Inc. CETX have seen a significant uptick amid pre-market trading. This boost comes on the heels of better-than-expected sales in the latest quarter, reporting an impressive $18.10 million in sales, surpassing the general analyst expectation of $16.39 million. This remarkable performance in sales has sparked...

Continue Reading
Exciting New PharmD-MBA Pathway Combines Pharmacy and Business

Updated Category News Views 193

Collaboration between Cal Poly Pomona and Western University In an exciting move, Cal Poly Pomona's Singelyn Graduate School of Business and Western University of Health Sciences have teamed up to create a groundbreaking pathway for aspiring healthcare professionals. This innovative PharmD-MBA program combines the fields of pharmacy and business, providing a unique...

Continue Reading
Kaskela Law Investigates Stock Misconduct in Stanley Black & Decker

Updated Category News Views 155

Overview of the Investigation by Kaskela Law LLC Kaskela Law LLC has announced an important investigation focused on Stanley Black & Decker, Inc. (NYSE: SWK) concerning allegations of potential securities fraud. This inquiry is primarily aimed at safeguarding the interests of long-term investors who hold shares in this well-known manufacturing company. Details Surrounding...

Continue Reading
Legend Biotech's Carvykti: A Leading Force in Cancer Treatment

Updated Category News Views 90

Redburn's Positive Outlook for Legend Biotech Recently, Redburn-Atlantic began covering Legend Biotech Corp. (NASDAQ: LEGN) with a favorable Buy rating and set a price target of $86.00 for the stock. This biotechnology company has made significant strides, particularly with the recent approval of its innovative product, Carvykti, designed for the treatment of multiple...

Continue Reading
Transforming the Anti-Obesity Drug Market for Future Success

Updated Category News Views 132

Global Anti-Obesity Drug Market Overview As global health concerns rise, the demand for anti-obesity drugs is surging. Recent reports estimate that the anti-obesity drug market will soar to USD 82.55 billion in the coming years. This impressive growth, fueled by an anticipated compound annual growth rate (CAGR) of 18.01%, signals a crucial moment for pharmaceutical...

Continue Reading